treatment with spironolactone resulted in more marked hyperreninism ( 47.0 +/- 14.3 ng-ml-1-3 hours-1 ) and hyperaldosteronism ( 61.9 +/-11.8 ng-100 ml-1 ) .
C0037982
spironolactone
C0020428
hyperaldosteronism